FindTrial
Sign In

Outcome of childhood acute lymphoblastic leukemia treated on SCMC-ALL-2005 protocol

Outcome of childhood acute lymphoblastic leukemia treated on SCMC-ALL-2005 protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PRNRC-07003002
Enrollment
Unknown
Registered
2007-11-21
Start date
2005-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lymphoblastic Leukemia

Interventions

Low Risk Group:Patients classified into low risk group receive low-risk group regimen treatment protocol
Medium Risk Group:Patients classified into medium risk group receive medium-risk group regimen treatment protocol
High Risk Group:Patients classified into high risk group receive high-risk group regimen treatment protocol

Sponsors

Shanghai Children’s Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1) Newly diagnosed childhood acute lymphoblastic leukemia; 2) Age<=18 years.

Exclusion criteria

Exclusion criteria: 1) Mature B-lineage acute lymphoblastic leukemia; 2) Receive chemotherapy by other institution outside of Shanghai Children's Medical Center.

Design outcomes

Primary

MeasureTime frame
Survival Rate;—

Countries

China

Contacts

Public ContactTang Jing Yan
yantfk@gmail.com+86 021 38626161-86061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026